Hows the Chicago DM & Coherus to work for?

Hi guys, any feedback would be appreciated ASAP. I've been in biotech for twenty years & now going through a downsizing---being recruited to Coherus. On a scale of 1-10, 10 being best, how would you rate Udenyca and Coherus to work for . THANK YOU.

 

It’s a contracted product, essentially a generic. All based on your payer coverage and what your current customer base is. This is not a salesman’s drug. The Chicago dm is a dolt but harmless. It will not help your oncology resume as biosims are not looked upon highly but if you’re looking to land it’s a simple job.

 

Run

 

This post is 2 years old. This poor bastard walks among us now and regrets every minute of it. Come join the resistance imbecile!

 

Why is the stock tanking with such a good pipeline?

 

Shitty management.

 

The stock is reacting to the
(i) overall mkt selloffs (ytd: <-10%) due to Fed Fund Rate expected march to 2% from 50bps, by EOY;
(ii) smart money rotating into value vs 'growtie' stock; and
(iii) [specifically to this co] udenyca sales plumetted from >US400m (2020) to ~US320m (FY2021) mostly from price decline.

Pipeline legit, but market being erratic assigning low probability for the successful commercialisaton of
(i) FDA approved Humira-biosimilar (Exp:yearly sales >2023 US1bn, 10% mkt share, with potential to scale production up to 30%); and
(ii) Udenyca-OBI/AI - Potentially capture ~50% Nuelasta-pro mkt (value: US0.5bn p.a.).

If you share this insight then by. If not find another co and/ or exit position.

May the force of evolution be w you.

 

Pipeline? You mean Yusimry? There are already 6 other humiras approved...this drug was stillborn from the moment the fda approved it, even though we refuse to admit it. Maybe you mean our lucenta biosim? Fun fact...nobody uses lucenta anymore bc its more invasive. What would the conversion of the miniscule market lucenta still commands do for us? Zero. Our only salvation is the on-body inj, and at best that gets us to maybe 30-35% of the neulasta market total for12-18 months...until theres a 3rd devise in the market. We are left with just biosims now & that business model has already been proven to be commercially unviable. Need proof? Novartis is dumping sandoz. The only hope for a future here was based upon a successful pivot into the pd1 market...already a long shot at best even with FDA approval being there are 6 others in the space. Now thats over. Nobody overcomes an fda crl, and if we do, itll be years down the road when nobody cares. We effectively need to rerun all our trials across all tumor types. Our stock peaked two years ago like others have said on here. Start looking.

 

You're right. This seems to be heading into a potential US50m - US150m cash crunch by Q1/Q2 2022, due to the fast declining Udenyca sales and high expenses.

Even with the tranche C (req. FDA's approval for Toripalimab for drawdown) and D (req. FDA's approval for lucentis biosimilar for drawdown) from the new debt facility, there would likely be a significant shortfall (US50m).

The new IB fella appointed to the board might be partly to 'conjure' up some financing. If that failed, Coherus might need to resort to right-size, and we all know what happened last time.

For the time being, all facts point to shitville.

 

How about a strawberry flavored Yusimry?

 

Well said, well thought out. It’s incredible how fast cash flow is bleeding

 

Maybe it will help if Reider shaves his head more.

 

Folks stock hit Another all time low…red
Flag warning, really is time to look out for one another - we took a chance and it failed, that’s ok.

 

I’m still waiting for that Reider head shaving thing to pay dividends.

 

Quick! Toss us more worthless equity to keep us. Hahah

 

We are just like Clovis and Puma now

 

No. Clovis and puma failed to gain approval of cutting edge drugs with totally new mechanisms of action. They took a chance to define markets. We failed to bring to market a 7th place pd1 retread that could be replicated by anyone with an IQ higher than their age. Big difference.

 

Such a doucher

 

"Dummy Lanfear is a process & manufacturing expert. It's what he did at Amgen, and look at that success. He is a saint!" Steve-o

Apparently the FDA believes otherwise...

 

Denny save us? I hope it's not because of his motivational speeches. He speaks on stage like an ADHD addled Corky Thatcher. Guy could'nt get a rise out of Ron Jeremy with one of his pep talks. The spawn of of a cross between Neville Chamberlain and PT Barnum would be more trustworthy and believable.